Table 4 Sero-converted animals according to other risk factors
Variable | Total sample (n) | Negative | Positive | Sero-conversion rate (%) | 95% Confidence interval | |
|---|---|---|---|---|---|---|
Upper | Lower | |||||
Age Months | ||||||
 Kid (0–3) | 2 | 0 | 2 | 100 | 0.3424 | 1.0000 |
 Young (4–9) | 105 | 84 | 21 | 20 | 0.1347 | 0.2865 |
 Adult (10–36) | 333 | 260 | 73 | 21.9 | 0.1781 | 0.2667 |
 Old (37–72) | 64 | 45 | 19 | 29.7 | 0.1991 | 0.4177 |
Gender | ||||||
 Female | 330 | 246 | 84 | 25.5 | 0.2105 | 0.3041 |
 Male | 174 | 143 | 31 | 17.8 | 0.1285 | 0.2418 |
Orf Lesion | ||||||
 Absent | 501 | 388 | 113 | 22.6 | 0.1911 | 0.2641 |
 Present | 3 | 1 | 2 | 66.7 | 0.2077 | 0.9385 |
History of orf | ||||||
 No | 504 | 389 | 115 | 22.82 | 0.1937 | 0.2668 |
 Yes | 0 | 0 | 0 | 0 | 0.0000 | 0.0000 |
Vaccine against orf | ||||||
 No | 504 | 389 | 115 | 22.82 | 0.1937 | 0.2668 |
 Yes | 0 | 0 | 0 | 0 | 0.0000 | 0.0000 |